Artificial intelligence based virtual screening study for competitive and allosteric inhibitors of the SARS-CoV-2 main protease

References

• Ahmed, W., Angel, N., Edson, J., Bibby, K., Bivins, A., O'Brien, J. W., Choi, P. M., Kitajima, M., Simpson, S. L., Li, J., Tscharke, B., Verhagen, R., Smith, W. J. M., Zaugg, J., Dierens, L., Hugenholtz, P., Thomas, K. V., & Mueller, J. F. (2020). First confirmed detection of SARS-CoV-2 in untreated wastewater in Australia: A proof of concept for the wastewater surveillance of COVID-19 in the community. The Science of the Total Environment, 728, 138764. https://doi.org/10.1016/j.scitotenv.2020.138764
   PubMed Web of Science ®Google Scholar
• Anand, K., Ziebuhr, J., Wadhwani, P., Mesters, J. R., & Hilgenfeld, R. (2003). Coronavirus main proteinase (3CLpro) Structure: Basis for design of anti-SARS drugs. Science, 300(5626), 1763–1767. https://doi.org/10.1126/SCIENCE.1085658/SUPPL_FILE/ANAND.SOM.PDF
   PubMed Web of Science ®Google Scholar
• Bauer, P., Hess, B., & Lindahl, E. (2022). GROMACS 2022.1 Manual. https://doi.org/10.5281/ZENODO.6451567
   Google Scholar
• Beard, H., Cholleti, A., Pearlman, D., Sherman, W., & Loving, K. A. (2013). Applying physics-based scoring to calculate free energies of binding for single amino acid mutations in protein-protein complexes. PLoS One, 8(12), e82849. https://doi.org/10.1371/JOURNAL.PONE.0082849
   PubMed Web of Science ®Google Scholar
• Chen, S., Chen, L., Tan, J., Chen, J., Du, L., Sun, T., Shen, J., Chen, K., Jiang, H., & Shen, X. (2005). Severe acute respiratory syndrome coronavirus 3C-like proteinase N terminus is indispensable for proteolytic activity but not for enzyme dimerization. Biochemical and thermodynamic investigation in conjunction with molecular dynamics simulations. The Journal of Biological Chemistry, 280(1), 164–173. https://doi.org/10.1074/JBC.M408211200
   PubMed Web of Science ®Google Scholar
• Chen, S., Jonas, F., Shen, C., & Hilgenfeld, R. (2010). Liberation of SARS-CoV main protease from the viral polyprotein: N-terminal autocleavage does not depend on the mature dimerization mode. Protein & Cell, 1(1), 59–74. https://doi.org/10.1007/s13238-010-0011-4
   PubMed Web of Science ®Google Scholar
• Chen, S., Zhang, J., Hu, T., Chen, K., Jiang, H., & Shen, X. (2008). Residues on the dimer interface of SARS coronavirus 3C-like protease: Dimer stability characterization and enzyme catalytic activity analysis. Journal of Biochemistry, 143(4), 525–536. https://doi.org/10.1093/jb/mvm246
   PubMed Web of Science ®Google Scholar
• Chou, C. Y., Chang, H. C., Hsu, W. C., Lin, T. Z., Lin, C. H., & Chang, G. G. (2004). Quaternary structure of the severe acute respiratory syndrome (SARS) coronavirus main protease. Biochemistry, 43(47), 14958–14970. https://doi.org/10.1021/BI0490237
   PubMed Web of Science ®Google Scholar
• COVID Live - Coronavirus Statistics – Worldometer. (2022). https://www.worldometers.info/coronavirus/.
   Google Scholar
• Current ICTV Taxonomy Release | ICTV. (2022). https://ictv.global/taxonomy.
   Google Scholar
• Dai, W., Zhang, B., Jiang, X.-M., Su, H., Li, J., Zhao, Y., Xie, X., Jin, Z., Peng, J., Liu, F., Li, C., Li, Y., Bai, F., Wang, H., Cheng, X., Cen, X., Hu, S., Yang, X., Wang, J., … Liu, H. (2020). Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease. Science (New York, N.Y.), 368(6497), 1331–1335. https://doi.org/10.1126/science.abb4489
   PubMed Web of Science ®Google Scholar
• Deodato, D., Asad, N., & Dore, T. M. (2022). Discovery of 2-thiobenzimidazoles as noncovalent inhibitors of SARS-CoV-2 main protease. Bioorganic and Medicinal Chemistry Letters. 72, 128867. https://doi.org/10.1016/j.bmcl.2022.128867
   PubMed Web of Science ®Google Scholar
• Douguet, D. (2010). e-LEA3D: A computational-aided drug design web server. Nucleic Acids Research. 38(Web Server), W615–W621. https://doi.org/10.1093/nar/gkq322
   PubMedGoogle Scholar
• Douguet, D., Munier-Lehmann, H., Labesse, G., & Pochet, S. (2005). LEA3D: A computer-aided ligand design for structure-based drug design. Journal of Medicinal Chemistry, 48(7), 2457–2468. https://doi.org/10.1021/jm0492296
   PubMed Web of Science ®Google Scholar
• Du, Q.-S., Wang, S.-Q., Zhu, Y., Wei, D.-Q., Guo, H., Sirois, S., & Chou, K.-C. (2004). Polyprotein cleavage mechanism of SARS CoV Mpro and chemical modification of the octapeptide. Peptides (N.Y), 25(11), 1857–1864. https://doi.org/10.1016/J.PEPTIDES.2004.06.018
   PubMed Web of Science ®Google Scholar
• El-Baba, T. J., Lutomski, C. A., Kantsadi, A. L., Malla, T. R., John, T., Mikhailov, V., Bolla, J. R., Schofield, C. J., Zitzmann, N., Vakonakis, I., & Robinson, C. V. (2020). Allosteric inhibition of the SARS-CoV-2 main protease: Insights from mass spectrometry based assays**. Angewandte Chemie, 132, 23750-23754. https://doi.org/10.1101/2020.07.29.226761
   Google Scholar
• Estrada, E. (2020). Topological analysis of SARS CoV-2 main protease. Chaos (Woodbury, N.Y.), 30(6), 061102. https://doi.org/10.1063/5.0013029
   PubMed Web of Science ®Google Scholar
• Fan, K., Wei, P., Feng, Q., Chen, S., Huang, C., Ma, L., Lai, B., Pei, J., Liu, Y., Chen, J., & Lai, L. (2004). Biosynthesis, purification, and substrate specificity of severe acute respiratory syndrome coronavirus 3C-like proteinase *. The Journal of Biological Chemistry, 279(3), 1637–1642. https://doi.org/10.1074/JBC.M310875200
   PubMed Web of Science ®Google Scholar
• Friesner, R. A., Banks, J. L., Murphy, R. B., Halgren, T. A., Klicic, J. J., Mainz, D. T., Repasky, M. P., Knoll, E. H., Shelley, M., Perry, J. K., Shaw, D. E., Francis, P., & Shenkin, P. S. (2004). Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. Journal of Medicinal Chemistry, 47(7), 1739–1749. https://doi.org/10.1021/JM0306430
   PubMed Web of Science ®Google Scholar
• Ge, R., Shen, Z., Yin, J., Chen, W., Zhang, Q., An, Y., Tang, D., Satz, A. L., Su, W., & Kuai, L. (2022). Discovery of SARS-CoV-2 main protease covalent inhibitors from a DNA-encoded library selection. SLAS Discovery : Advancing Life Sciences R & D, 27(2), 79–85. https://doi.org/10.1016/j.slasd.2022.01.001
   PubMed Web of Science ®Google Scholar
• Gentile, F., Yaacoub, J. C., Gleave, J., Fernandez, M., Ton, A.-T., Ban, F., Stern, A., & Cherkasov, A. (2022). Artificial intelligence–enabled virtual screening of ultra-large chemical libraries with deep docking. Nature Protocols, 17(3), 672–697. https://doi.org/10.1038/s41596-021-00659-2
   PubMed Web of Science ®Google Scholar
• Gordon, D. E., Jang, G. M., Bouhaddou, M., Xu, J., Obernier, K., White, K. M., O'Meara, M. J., Rezelj, V. V., Guo, J. Z., Swaney, D. L., Tummino, T. A., Hüttenhain, R., Kaake, R. M., Richards, A. L., Tutuncuoglu, B., Foussard, H., Batra, J., Haas, K., Modak, M., … Krogan, N. J. (2020). A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature, 583(7816), 459–468. https://doi.org/10.1038/s41586-020-2286-9
   PubMed Web of Science ®Google Scholar
• Greenwood, J. R., Calkins, D., Sullivan, A. P., & Shelley, J. C. (2010). Towards the comprehensive, rapid, and accurate prediction of the favorable tautomeric states of drug-like molecules in aqueous solution. Journal of Computer-Aided Molecular Design, 24(6–7), 591–604. Jun https://doi.org/10.1007/s10822-010-9349-1
   PubMed Web of Science ®Google Scholar
• Grottesi, A., Bešker, N., Emerson, A., Manelfi, C., Beccari, A. R., Frigerio, F., Lindahl, E., Cerchia, C., & Talarico, C. (2022). Computational studies of SARS-CoV-2 3CLpro: Insights from MD simulations. https://www.mdpi.com/781406
   Google Scholar
• Günther, S., Reinke, P.Y., Fernández-García, Y., Lieske, J., Lane, T.J., Ginn, H.M., Koua, F.H., Ehrt, C., Ewert, W., Oberthuer, D., & Yefanov, O. (2021) X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease. Science, 372, 642–646.
   Google Scholar
• Hakami, A. R., Bakheit, A. H., Almehizia, A. A., & Ghazwani, M. Y. (2022). Selection of SARS-CoV-2 main protease inhibitor using structure-based virtual screening. Future Medicinal Chemistry, 14(2), 61–79. https://doi.org/10.4155/fmc-2020-0380
   PubMed Web of Science ®Google Scholar
• Harder, E., Damm, W., Maple, J., Wu, C., Reboul, M., Xiang, J. Y., Wang, L., Lupyan, D., Dahlgren, M. K., Knight, J. L., Kaus, J. W., Cerutti, D. S., Krilov, G., Jorgensen, W. L., Abel, R., & Friesner, R. A. (2016). OPLS3: A force field providing broad coverage of drug-like small molecules and proteins. Journal of Chemical Theory and Computation, 12(1), 281–296. https://doi.org/10.1021/ACS.JCTC.5B00864/SUPPL_FILE/CT5B00864_SI_001.ZIP
   PubMed Web of Science ®Google Scholar
• Hariyono, P., Dwiastuti, R., Yusuf, M., Salin, N. H., & Hariono, M. (2022). 2-Phenoxyacetamide derivatives as SARS-CoV-2 main protease inhibitor: In silico studies. Results Chem, 4, 100263. https://doi.org/10.1016/j.rechem.2021.100263
   PubMedGoogle Scholar
• Hemmati, S. A., & Tabein, S. (2022). Insect protease inhibitors; promising inhibitory compounds against SARS-CoV-2 main protease. Computers in Biology and Medicine. 142, 105228. Mar https://doi.org/10.1016/j.compbiomed.2022.105228
   PubMed Web of Science ®Google Scholar
• Hsu, W. C., Chang, H. C., Chou, C. Y., Tsai, P. J., Lin, P. I., & Chang, G. G. (2005). Critical assessment of important regions in the subunit association and catalytic action of the severe acute respiratory syndrome coronavirus main protease. The Journal of Biological Chemistry, 280(24), 22741–22748. https://doi.org/10.1074/JBC.M502556200
   PubMed Web of Science ®Google Scholar
• Huff, S., Kummetha, I. R., Tiwari, S. K., Huante, M. B., Clark, A. E., Wang, S., Bray, W., Smith, D., Carlin, A. F., Endsley, M., & Rana, T. M. (2022). Discovery and mechanism of SARS-CoV-2 main protease inhibitors. Journal of Medicinal Chemistry, 65(4), 2866–2879. https://doi.org/10.1021/acs.jmedchem.1c00566
   PubMed Web of Science ®Google Scholar
• Iftikhar, H., Ali, H. N., Farooq, S., Naveed, H., & Shahzad-Ul-Hussan, S. (2020). Identification of potential inhibitors of three key enzymes of SARS-CoV2 using computational approach. Computers in Biology and Medicine, 122, 103848. https://doi.org/10.1016/J.COMPBIOMED.2020.103848
   PubMed Web of Science ®Google Scholar
• Jiménez, J., Sabbadin, D., Cuzzolin, A., Martínez-Rosell, G., Gora, J., Manchester, J., Duca, J., & De Fabritiis, G. (2019). PathwayMap: Molecular pathway association with self-normalizing neural networks. Journal of Chemical Information and Modeling, 59(3), 1172–1181. https://doi.org/10.1021/acs.jcim.8b00711
   PubMed Web of Science ®Google Scholar
• Jin, Z., Du, X., Xu, Y., Deng, Y., Liu, M., Zhao, Y., Zhang, B., Li, X., Zhang, L., Peng, C., Duan, Y., Yu, J., Wang, L., Yang, K., Liu, F., Jiang, R., Yang, X., You, T., Liu, X., … Yang, H. (2020). Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature, 582(7811), 289–293. https://doi.org/10.1038/s41586-020-2223-y
   PubMed Web of Science ®Google Scholar
• Jones, G., Willett, P., Glen, R. C., Leach, A. R., & Taylor, R. (1997). Development and validation of a genetic algorithm for flexible docking. Journal of Molecular Biology, 267(3), 727–748. https://doi.org/10.1006/jmbi.1996.0897
   PubMed Web of Science ®Google Scholar
• Jorgensen, W. L., Maxwell, D. S., & Tirado-Rives, J. (1996). Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids. Journal of the American Chemical Society, 118(45), 11225–11236. https://doi.org/10.1021/JA9621760/SUPPL_FILE/JA11225.PDF
   Web of Science ®Google Scholar
• Keillor, J. W., & Brown, R. S. (1992). Attack of Zwitterionic Ammonium Thiolates on a distorted anilide as a model for the acylation of papain by amides. A simple demonstration of a bell-shaped pH/rate profile. Journal of the American Chemical Society, 114(21), 7983–7989. https://doi.org/10.1021/JA00047A004/SUPPL_FILE/JA00047A004_SI_001.PDF
   Web of Science ®Google Scholar
• Kesari, P., Deshmukh, A., Pahelkar, N., Suryawanshi, A. B., Rathore, I., Mishra, V., Dupuis, J. H., Xiao, H., Gustchina, A., Abendroth, J., Labaied, M., Yada, R. Y., Wlodawer, A., Edwards, T. E., Lorimer, D. D., & Bhaumik, P. (2022). Structures of plasmepsin X from Plasmodium falciparum reveal a novel inactivation mechanism of the zymogen and molecular basis for binding of inhibitors in mature enzyme. Protein Science, 31(4), 882–899. https://doi.org/10.1002/pro.4279
   PubMedGoogle Scholar
• Kitamura, N., Sacco, M. D., Ma, C., Hu, Y., Townsend, J. A., Meng, X., Zhang, F., Zhang, X., Ba, M., Szeto, T., Kukuljac, A., Marty, M. T., Schultz, D., Cherry, S., Xiang, Y., Chen, Y., & Wang, J. (2022). Expedited approach toward the rational design of noncovalent SARS-CoV-2 main protease inhibitors. Journal of Medicinal Chemistry, 65(4), 2848–2865. https://doi.org/10.1021/acs.jmedchem.1c00509
   PubMed Web of Science ®Google Scholar
• Kneller, D. W., Li, H., Phillips, G., Weiss, K. L., Zhang, Q., Arnould, M. A., Jonsson, C. B., Surendranathan, S., Parvathareddy, J., Blakeley, M. P., Coates, L., Louis, J. M., Bonnesen, P. V., & Kovalevsky, A. (2022). Covalent narlaprevir- and boceprevir-derived hybrid inhibitors of SARS-CoV-2 main protease. Nature Communications, 13(1), 11. https://doi.org/10.1038/s41467-022-29915-z
   Web of Science ®Google Scholar
• Korb, O., Stützle, T., & Exner, T. E. (2009). Empirical scoring functions for advanced protein-ligand docking with PLANTS. Journal of Chemical Information and Modeling, 49(1), 84–96. https://doi.org/10.1021/CI800298Z
   PubMed Web of Science ®Google Scholar
• Kozakov, D., Brenke, R., Comeau, S. R., & Vajda, S. (2006). PIPER: An FFT-based protein docking program with pairwise potentials. Proteins, 65(2), 392–406. https://doi.org/10.1002/PROT.21117
   PubMed Web of Science ®Google Scholar
• Kuzikov, M., Costanzi, E., Reinshagen, J., Esposito, F., Vangeel, L., Wolf, M., Ellinger, B., Claussen, C., Geisslinger, G., Corona, A., Iaconis, D., Talarico, C., Manelfi, C., Cannalire, R., Rossetti, G., Gossen, J., Albani, S., Musiani, F., Herzog, K., … Zaliani, A. (2021). Identification of inhibitors of SARS-CoV-2 3CL-Pro enzymatic activity using a small molecule in vitro repurposing screen. ACS Pharmacology & Translational Science, 4(3), 1096–1110. https://doi.org/10.1021/acsptsci.0c00216
   PubMedGoogle Scholar
• Li, C., Qi, Y., Teng, X., Yang, Z., Wei, P., Zhang, C., Tan, L., Zhou, L., Liu, Y., & Lai, L. (2010). Maturation mechanism of severe acute respiratory syndrome (SARS) coronavirus 3C-like proteinase. The Journal of Biological Chemistry, 285(36), 28134–28140. https://doi.org/10.1074/jbc.M109.095851
   PubMed Web of Science ®Google Scholar
• Lu, C., Wu, C., Ghoreishi, D., Chen, W., Wang, L., Damm, W., Ross, G. A., Dahlgren, M. K., Russell, E., Von Bargen, C. D., Abel, R., Friesner, R. A., & Harder, E. D. (2021). OPLS4: Improving force field accuracy on challenging regimes of chemical space. Journal of Chemical Theory and Computation, 17(7), 4291–4300. https://doi.org/10.1021/ACS.JCTC.1C00302
   PubMed Web of Science ®Google Scholar
• Luttens, A., Gullberg, H., Abdurakhmanov, E., Vo, D. D., Akaberi, D., Talibov, V. O., Nekhotiaeva, N., Vangeel, L., De Jonghe, S., Jochmans, D., Krambrich, J., Tas, A., Lundgren, B., Gravenfors, Y., Craig, A. J., Atilaw, Y., Sandström, A., Moodie, L. W. K., Lundkvist, Å., … Carlsson, J. (2022). Ultralarge virtual screening identifies SARS-CoV-2 main protease inhibitors with broad-spectrum activity against coronaviruses. Journal of the American Chemical Society, 144(7), 2905–2920. https://doi.org/10.1021/jacs.1c08402
   PubMed Web of Science ®Google Scholar
• Ma, C., Sacco, M. D., Hurst, B., Townsend, J. A., Hu, Y., Szeto, T., Zhang, X., Tarbet, B., Marty, M. T., Chen, Y., & Wang, J. (2020). Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease. Cell Research, 30(8), 678–692. https://doi.org/10.1038/s41422-020-0356-z
   PubMed Web of Science ®Google Scholar
• Ma, X. R., Alugubelli, Y. R., Ma, Y., Vatansever, E. C., Scott, D. A., Qiao, Y., Yu, G., Xu, S., & Liu, W. R. (2022). MPI8 is potent against SARS-CoV-2 by inhibiting dually and selectively the SARS-CoV-2 main protease and the host Cathepsin L**. ChemMedChem. 17(1), e202100456. https://doi.org/10.1002/cmdc.202100456
   Web of Science ®Google Scholar
• Mengist, H. M., Fan, X., & Jin, T. (2020). Designing of improved drugs for COVID-19: Crystal structure of SARS-CoV-2 main protease Mpro. Signal Transduction and Targeted Therapy, 5(1), 1–2. https://doi.org/10.1038/s41392-020-0178-y
   PubMed Web of Science ®Google Scholar
• Morgan, H. L. (1965). The generation of a unique machine description for chemical structures—A technique developed at chemical abstracts service. Journal of Chemical Documentation, 5(2), 107–113. https://doi.org/10.1021/C160017A018/ASSET/C160017A018.FP.PNG_V03
   Google Scholar
• Muramatsu, T., Kim, Y. T., Nishii, W., Terada, T., Shirouzu, M., & Yokoyama, S. (May 2013). Autoprocessing mechanism of severe acute respiratory syndrome coronavirus 3C-like protease (SARS-CoV 3CLpro) from its polyproteins. The FEBS Journal, 280(9), 2002–2013. https://doi.org/10.1111/FEBS.12222
   PubMed Web of Science ®Google Scholar
• Naqvi, A. A. T., Fatima, K., Mohammad, T., Fatima, U., Singh, I. K., Singh, A., Atif, S. M., Hariprasad, G., Hasan, G. M., & Hassan, M. I. (2020). Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach. Biochimica et Biophysica Acta - Molecular Basis of Disease, 1866(10), 165878. https://doi.org/10.1016/j.bbadis.2020.165878
   PubMed Web of Science ®Google Scholar
• Noske, G. D., Nakamura, A. M., Gawriljuk, V. O., Fernandes, R. S., Lima, G. M. A., Rosa, H. V. D., Pereira, H. D., Zeri, A. C. M., Nascimento, A. F. Z., Freire, M., Fearon, D., Douangamath, A., von Delft, F., Oliva, G., & Godoy, A. S. (2021). A crystallographic snapshot of SARS-CoV-2 main protease maturation process: SARS-CoV-2 Mpro maturation. Journal of Molecular Biology, 433(18), 167118. https://doi.org/10.1016/j.jmb.2021.167118
   PubMed Web of Science ®Google Scholar
• O'Boyle, N. M., Banck, M., James, C. A., Morley, C., Vandermeersch, T., & Hutchison, G. R. (2011). Open Babel: An open chemical toolbox. Journal of Cheminformatics, 3(1), 1–14. https://doi.org/10.1186/1758-2946-3-33/TABLES/2
   PubMed Web of Science ®Google Scholar
• Pathak, N., Chen, Y.-T., Hsu, Y.-C., Hsu, N.-Y., Kuo, C.-J., Tsai, H. P., Kang, J.-J., Huang, C.-H., Chang, S.-Y., Chang, Y.-H., Liang, P.-H., & Yang, J.-M. (2021). Uncovering flexible active site conformations of SARS-CoV-2 3CL proteases through protease pharmacophore clusters and COVID-19 drug repurposing. ACS Nano, 15(1), 857–872. https://doi.org/10.1021/acsnano.0c07383
   PubMed Web of Science ®Google Scholar
• Payne, S. (2017). Family coronaviridae. In Viruses (p. 149). Academic press. https://doi.org/10.1016/B978-0-12-803109-4.00017-9
   Google Scholar
• Pillaiyar, T., Flury, P., Krüger, N., Su, H., Schäkel, L., Barbosa Da Silva, E., Eppler, O., Kronenberger, T., Nie, T., Luedtke, S., Rocha, C., Sylvester, K., Petry, M. R., McKerrow, J. H., Poso, A., Pöhlmann, S., Gütschow, M., O’Donoghue, A. J., Xu, Y., Müller, C. E., & Laufer, S. A. (2022). Small-molecule thioesters as SARS-CoV-2 main protease inhibitors: Enzyme inhibition, structure–activity relationships, antiviral activity, and X-ray structure determination. Journal of Medicinal Chemistry, 65(13), 9376–9395. https://doi.org/10.1021/acs.jmedchem.2c00636
   PubMedGoogle Scholar
• Pillaiyar, T., Manickam, M., Namasivayam, V., Hayashi, Y., & Jung, S. H. (2016). An Overview of Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 3CL protease inhibitors: peptidomimetics and small molecule chemotherapy. Journal of Medicinal Chemistry, 59(14), 6595–6628. https://doi.org/10.1021/ACS.JMEDCHEM.5B01461
   PubMed Web of Science ®Google Scholar
• qpld manual - Google Search https://www.google.com/search?client=firefox-b-d&q=qpld+manual+.
   Google Scholar
• Samrat, S. K., Xu, J., Xie, X., Gianti, E., Chen, H., Zou, J., Pattis, J. G., Elokely, K., Lee, H., Li, Z., Klein, M. L., Shi, P.-Y., Zhou, J., & Li, H. (2022). Allosteric inhibitors of the main protease of SARS-CoV-2. Antiviral Research, 205, 105381. https://doi.org/10.1016/j.antiviral.2022.105381
   PubMed Web of Science ®Google Scholar
• Sapundzhi, F., Prodanova, K., & Lazarova, M. (2019). Survey of the scoring functions for protein-ligand docking [Paper presentation]. In AIP Conference Proceedings, vol. 2172. https://doi.org/10.1063/1.5133601
   Google Scholar
• Schrodinger. (2015). Schrödinger Press Glide User Manual Glide 6.7 User Manual Glide User Manual.
   Google Scholar
• Schüttelkopf, A. W., & van Aalten, D. M. F. (2004). PRODRG: A tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallographica. Section D, Biological Crystallography, 60(Pt 8), 1355–1363. https://doi.org/10.1107/S0907444904011679
   PubMedGoogle Scholar
• Sencanski, M., Perovic, V., Pajovic, S. B., Adzic, M., Paessler, S., & Glisic, S. (2020). Drug repurposing for candidate SARS-CoV-2 main protease inhibitors by a novel in silico method. Molecules, 25(17), 3830. https://doi.org/10.3390/molecules25173830
   PubMed Web of Science ®Google Scholar
• Shelley, J. C., Cholleti, A., Frye, L. L., Greenwood, J. R., Timlin, M. R., & Uchimaya, M. (2007). Epik: A software program for pKa prediction and protonation state generation for drug-like molecules. Journal of Computer-Aided Molecular Design, 21(12), 681–691. https://doi.org/10.1007/s10822-007-9133-z
   PubMed Web of Science ®Google Scholar
• Shie, J.-J., Fang, J.-M., Kuo, T.-H., Kuo, C.-J., Liang, P.-H., Huang, H.-J., Wu, Y.-T., Jan, J.-T., Cheng, Y.-S E., & Wong, C.-H. (2005). Inhibition of the severe acute respiratory syndrome 3CL protease by peptidomimetic alpha,beta-unsaturated esters. Bioorganic & Medicinal Chemistry, 13(17), 5240–5252. https://doi.org/10.1016/J.BMC.2005.05.065
   PubMed Web of Science ®Google Scholar
• Shree, P., Mishra, P., Selvaraj, C., Singh, S. K., Chaube, R., Garg, N., & Tripathi, Y. B. (2022). Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants–Withania somnifera (Ashwagandha), Tinospora cordifolia (Giloy) and Ocimum sanctum (Tulsi)–a molecular docking study. Journal of Biomolecular Structure & Dynamics, 40(1), 190–203. https://doi.org/10.1080/07391102.2020.1810778
   PubMed Web of Science ®Google Scholar
• Tahir Ul Qamar, M., Alqahtani, S. M., Alamri, M. A., & Chen, L. L. (2020). Structural basis of SARS-CoV-2 3CL pro and anti-COVID-19 drug discovery from medicinal plants. Journal of Pharmaceutical Analysis, 10(4), 313–319. https://doi.org/10.1016/J.JPHA.2020.03.009
   PubMed Web of Science ®Google Scholar
• Tong, X., Liu, X., Tan, X., Li, X., Jiang, J., Xiong, Z., Xu, T., Jiang, H., Qiao, N., & Zheng, M. (2021). Generative models for de novo drug design. Journal of Medicinal Chemistry, 64(19), 14011–14027. https://doi.org/10.1021/acs.jmedchem.1c00927
   PubMed Web of Science ®Google Scholar
• Trott, O., & Olson, A. J. (2009). AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31(2), 455–461. https://doi.org/10.1002/jcc.21334
   Web of Science ®Google Scholar
• Ullrich, S., & Nitsche, C. (2020). The SARS-CoV-2 main protease as drug target. Bioorganic & Medicinal Chemistry Letters, 30(17), 127377. https://doi.org/10.1016/J.BMCL.2020.127377
   PubMed Web of Science ®Google Scholar
• Verma, S., & Pandey, A. K. (2021). Factual insights of the allosteric inhibition mechanism of SARS-CoV-2 main protease by quercetin: an in silico analysis. 3 Biotech, 11(2), 10. https://doi.org/10.1007/s13205-020-02630-6
   Google Scholar
• Vuong, W., Khan, M. B., Fischer, C., Arutyunova, E., Lamer, T., Shields, J., Saffran, H. A., McKay, R. T., van Belkum, M. J., Joyce, M. A., Young, H. S., Tyrrell, D. L., Vederas, J. C., & Lemieux, M. J. (2020). Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication. Nature Communications, 11(1), 8. https://doi.org/10.1038/s41467-020-18096-2
   Web of Science ®Google Scholar
• Wang, Z., Sun, H., Yao, X., Li, D., Xu, L., Li, Y., Tian, S., & Hou, T. (2016). Comprehensive evaluation of ten docking programs on a diverse set of protein–ligand complexes: The prediction accuracy of sampling power and scoring power. Physical Chemistry Chemical Physics : PCCP, 18(18), 12964–12975. https://doi.org/10.1039/C6CP01555G
   PubMed Web of Science ®Google Scholar
• Xue, X., Yu, H., Yang, H., Xue, F., Wu, Z., Shen, W., Li, J., Zhou, Z., Ding, Y., Zhao, Q., Zhang, X. C., Liao, M., Bartlam, M., & Rao, Z. (2008). Structures of two coronavirus main proteases: Implications for substrate binding and antiviral drug design. Journal of Virology, 82(5), 2515–2527. https://doi.org/10.1128/JVI.02114-07
   PubMed Web of Science ®Google Scholar
• Yamamoto, N., Yang, R., Yoshinaka, Y., Amari, S., Nakano, T., Cinatl, J., Rabenau, H., Doerr, H. W., Hunsmann, G., Otaka, A., Tamamura, H., Fujii, N., & Yamamoto, N. (2004). HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus. Available: https://www.sciencedirect.com/science/article/pii/S0006291X04008150?casa_token=GM70WnQOukUAAAAA:zB1V2tTIuiObkEqcppGNjlS0z4TZFNJO8AWPaENBLDRPZqa70oXvTJjKCOSHnyspDrnDKIQZY6PR
   Google Scholar
• Yang, H., Yang, M., Ding, Y., Liu, Y., Lou, Z., Zhou, Z., Sun, L., Mo, L., Ye, S., Pang, H., Gao, G. F., Anand, K., Bartlam, M., Hilgenfeld, R., & Rao, Z. (2003). The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proceedings of the National Academy of Sciences of the United States of America, 100(23), 13190–13195. https://doi.org/10.1073/PNAS.1835675100
   PubMed Web of Science ®Google Scholar
• Yoshino, R., Yasuo, N., & Sekijima, M. (2020). Identification of key interactions between SARS-CoV-2 main protease and inhibitor drug candidates. Scientific Reports, 10(1), 1–8. https://doi.org/10.1038/s41598-020-69337-9
   PubMed Web of Science ®Google Scholar
• Zhang, Y. Z., & Holmes, E. C. (2020). A genomic perspective on the origin and emergence of SARS-CoV-2. Cell, 181(2), 223–227. https://doi.org/10.1016/j.cell.2020.03.035
   PubMed Web of Science ®Google Scholar
• Zhang, L., Lin, D., Kusov, Y., Nian, Y., Ma, Q., Wang, J., von Brunn, A., Leyssen, P., Lanko, K., Neyts, J., de Wilde, A., Snijder, E. J., Liu, H., & Hilgenfeld, R. (2020). α-Ketoamides as broad-spectrum inhibitors of coronavirus and enterovirus replication: Structure-based design, synthesis, and activity assessment. Journal of Medicinal Chemistry, 63(9), 4562–4578. https://doi.org/10.1021/acs.jmedchem.9b01828
   PubMed Web of Science ®Google Scholar
• Zhang, L., Lin, D., Sun, X., Curth, U., Drosten, C., Sauerhering, L., Becker, S., Rox, K., & Hilgenfeld, R. (2020). Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved a-ketoamide inhibitors. Science (New York, N.Y.), 368(6489), 409–412. https://doi.org/10.1126/SCIENCE.ABB3405/SUPPL_FILE/PAPV2.PDF
   PubMed Web of Science ®Google Scholar
• Zhang, X. W., & Yap, Y. L. (2004). Old drugs as lead compounds for a new disease? Binding analysis of SARS coronavirus main proteinase with HIV, psychotic and parasite drugs. https://www.sciencedirect.com/science/article/pii/S0968089604002214
   Google Scholar
• Zhao, Y., Fang, C., Zhang, Q., Zhang, R., Zhao, X., Duan, Y., Wang, H., Zhu, Y., Feng, L., Zhao, J., Shao, M., Yang, X., Zhang, L., Peng, C., Yang, K., Ma, D., Rao, Z., & Yang, H. (2022). Crystal structure of SARS-CoV-2 main protease in complex with protease inhibitor PF-07321332. Protein & Cell, 13(9), 689–693. https://doi.org/10.1007/s13238-021-00883-2
   PubMed Web of Science ®Google Scholar
• Zhong, N., Zhang, S., Zou, P., Chen, J., Kang, X., Li, Z., Liang, C., Jin, C., & Xia, B. (2008). Without its N-finger, the main protease of severe acute respiratory syndrome coronavirus can form a novel dimer through its C-terminal domain. Journal of Virology, 82(9), 4227–4234. https://doi.org/10.1128/jvi.02612-07
   PubMed Web of Science ®Google Scholar